PIK3CA and cancer: Almost all gene mutations in TP53, PIK3CA, H-RAS, BRAF, and AKT1 that were identified in this study were covered by the Catalogue of Somatic Mutations in Cancer (COSMIC), and most of these mutations are oncogenic, for which a functional analysis has already been performed [58–62].